Skip to content
OpenCapital
Get started

LENZ Therapeutics, Inc. LENZ Q4 2024 Annual earnings

Reported March 19, 2025 · After market close

EPS-$0.46Miss by $0.04
EPS estimate-$0.42

Next report

Jul 29, 2026 (Today)
Revenue estimate$2.4M
EPS estimate-$1.05

Versus estimates

Revenue

Q1 2026$1.9MBeat by $142.1KQ4 2025$1.6MMiss by $1.5MQ3 2025$12.5MBeat by $9.5MQ2 2025$5.0MBeat by $4.3M

Diluted EPS

Q1 2026-$1.32Miss by $0.22Q4 2025-$1.16Miss by $0.25Q3 2025-$0.59Beat by $0.08Q2 2025-$0.53Beat by $0.05Q1 2025-$0.53Beat by $0.02
Q4 2024-$0.46Miss by $0.04

Ask the moment LENZ Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did LENZ Therapeutics, Inc. report Q4 2024 earnings?
LENZ Therapeutics, Inc. (LENZ) reported Q4 2024 earnings on March 19, 2025 after market close.
What were LENZ Therapeutics, Inc.'s Q4 2024 revenue and EPS?
LENZ Therapeutics, Inc. reported eps of $-0.46 for Q4 2024.
Did LENZ Therapeutics, Inc. beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.42 by $0.04.
Where can I find LENZ Therapeutics, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001815776-25-000019) directly on SEC EDGAR. The filing index links above go to sec.gov.